// App-Quantinova.ai

1177-73 : RIVAROXABAN FOR THE TREATMENT OF SYMPTOMATIC VENOUS THROMBOEMBOLISM: IS THERE A NEED FOR INITIAL HEPARIN TREATMENT? A SUBGROUP ANALYSIS OF THE EINSTEIN DVT AND PE STUDIES

Researchers

Presenter

  • Anthonie W.A. Lensing

Principal Investigators

  • N/A

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • Bayer

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

  • Enoxaparin

  • Enoxaparin sodium

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved